Tag: Real World Data
The Scary Future of Rare Disease Management
In a world of rising healthcare costs, the greatest nightmare for payers is reimbursing drug interventions that do not meaningfully benefit their covered lives. Rare disease therapies, often viewed as attractive areas for pharmaceutical & biotech manufacturers, represent some of the most expensive interventions available today given inherently limited competition. Yet, as more manufacturers enter … Continued
Bio-Europe Digital
AMCP Nexus 2021
Three Pathways have emerged in Innovative Access Agreements
The days of simply determining the market demand for a new drug as a function of price and choosing the revenue or profit optimizing point are gone. In our new environment, an explicit rationale, the “value-based price” has become a prerequisite for enabling conversation with payers while policy-makers seem poised to limit the pricing corridors … Continued
Outcomes Based Agreements
The days of simply determining the market demand for a new drug as a function of price and choosing the revenue or profit optimizing point are gone. In our new environment, an explicit rationale, the “value-based price” has become a prerequisite for enabling conversation with payers while policy-makers seem poised to limit the pricing corridors … Continued
SNDS: A Goldmine for Effective Decision Making?
Real-World Data (RWD) have been increasingly used to further understand the natural history of a disease or condition, treatment patterns in RW practice, as well as the effectiveness, safety and costs associated with treatment options. They help exploring research questions, potentially complement clinical trial findings, and fill knowledge gaps. Different existing data sources can be … Continued
Stakeholder perspectives: current and potential benefits
ヨーロッパの実世界のデータソースの中で、フランスのヘルスケアデータベースSNDSは、最大かつ最も包括的なヘルスケアデータリソースであり、フランス人口の99%以上、ヨーロッパの10％程度に相当する... Watch this short video by Nadia Quignot, Director, Decision Analytics & Real World Evidence at … Continued
ケーススタディを通して見る欧州におけるHTAと市場アクセスの強みと機会
ヨーロッパの実世界のデータソースの中で、フランスのヘルスケアデータベースSNDSは、最大かつ最も包括的なヘルスケアデータリソースであり、フランス人口の99%以上、ヨーロッパの10％程度に相当する... In this short video by Nadia Quignot, Director, Decision Analytics & Real World Evidence at … Continued
Similarities and differences between SNDS and other claim databases
ヨーロッパの実世界のデータソースの中で、フランスのヘルスケアデータベースSNDSは、最大かつ最も包括的なヘルスケアデータリソースであり、フランス人口の99%以上、ヨーロッパの10％程度に相当する... Watch this short clip by Nadia Quignot, Director, Decision Analytics & Real World Evidence at … Continued
